Platinum-resistant Epithelial Ovarian Cancer

DBCOND0087629Adnexa uteri massEndocrine System Diseases

Platinum-resistant Epithelial Ovarian Cancer is the indication for 4 drugs in DrugBank. It is covered by 8 curated, structured indications.

Classified under
Indicated drugs

What you can answer from here — as of October 22, 2026

4Indicated drugsWith each drug's targets and mechanism
Listed above
8Structured indicationsPopulation, line of therapy, route and combination as fields, not prose
Sign in
4Clinical trialsPhase, status and sponsor resolved per trial
Sign in

Which approved drugs for Platinum-resistant Epithelial Ovarian Cancer share a target, and which companies have late-stage candidates against it?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In